Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 118

1.

Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?

von der Grün J, Rödel F, Brandts C, Fokas E, Guckenberger M, Rödel C, Balermpas P.

Cancers (Basel). 2019 Apr 3;11(4). pii: E472. doi: 10.3390/cancers11040472. Review.

2.

NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells-A Potential Target for Adjuvant Radiotherapy.

Müller-Längle A, Lutz H, Hehlgans S, Rödel F, Rau K, Laube B.

Cancers (Basel). 2019 Apr 9;11(4). pii: E503. doi: 10.3390/cancers11040503.

3.

Arsenic Trioxide and (-)-Gossypol Synergistically Target Glioma Stem-Like Cells via Inhibition of Hedgehog and Notch Signaling.

Linder B, Wehle A, Hehlgans S, Bonn F, Dikic I, Rödel F, Seifert V, Kögel D.

Cancers (Basel). 2019 Mar 12;11(3). pii: E350. doi: 10.3390/cancers11030350.

4.

Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial.

Diefenhardt M, Hofheinz RD, Martin D, Beißbarth T, Arnold D, Hartmann A, von der Grün J, Grützmann R, Liersch T, Ströbel P, Grabenbauer GG, Rieger M, Fietkau R, Graeven U, Weitz J, Folprecht G, Ghadimi M, Rödel F, Rödel C, Fokas E; German Rectal Cancer Study Group.

Int J Cancer. 2019 Mar 14. doi: 10.1002/ijc.32274. [Epub ahead of print]

PMID:
30868576
5.

Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability.

Raab M, Sanhaji M, Zhou S, Rödel F, El-Balat A, Becker S, Strebhardt K.

Neoplasia. 2019 Apr;21(4):363-375. doi: 10.1016/j.neo.2019.01.007. Epub 2019 Mar 7.

6.

Merkel Cell Polyoma Viral Load and Intratumoral CD8+ Lymphocyte Infiltration Predict Overall Survival in Patients With Merkel Cell Carcinoma.

von der Grün J, Winkelmann R, Meissner M, Wieland U, Silling S, Martin D, Fokas E, Rödel C, Rödel F, Balermpas P.

Front Oncol. 2019 Jan 24;9:20. doi: 10.3389/fonc.2019.00020. eCollection 2019.

7.

Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy.

Rödel F, Martin D, Balermpas P, Wieland U, Winkelmann R, Riekmann T, Falk S, Rödel C, Fokas E.

Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):126-137. doi: 10.1016/j.bbcan.2018.12.006. Epub 2018 Dec 31. Review.

PMID:
30605716
8.

Is it time to redefine the role of low-dose radiotherapy for benign disease?

Montero A, Sabater S, Rödel F, Gaipl US, Ott OJ, Seegenschmiedt MH, Arenas M.

Ann Rheum Dis. 2018 Dec 21. pii: annrheumdis-2018-214873. doi: 10.1136/annrheumdis-2018-214873. [Epub ahead of print] No abstract available.

PMID:
30578294
9.

Low-dose radiotherapy: Mayday, mayday. We've been hit!

Ott OJ, Micke O, Mücke R, Niewald M, Rödel F, Schäfer U, Seegenschmiedt MH, Arenas M, Frey B, Gaipl US; German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD).

Strahlenther Onkol. 2019 Apr;195(4):285-288. doi: 10.1007/s00066-018-1412-1. Epub 2018 Dec 18. No abstract available.

PMID:
30564845
10.

Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.

Hehlgans S, Booms P, Güllülü Ö, Sader R, Rödel C, Balermpas P, Rödel F, Ghanaati S.

Int J Mol Sci. 2018 Aug 23;19(9). pii: E2485. doi: 10.3390/ijms19092485.

11.

Ionizing radiation reduces the capacity of activated macrophages to induce T-cell proliferation, but does not trigger dendritic cell-mediated non-targeted effects.

Wunderlich R, Rühle PF, Deloch L, Rödel F, Fietkau R, Gaipl US, Frey B.

Int J Radiat Biol. 2019 Jan;95(1):33-43. doi: 10.1080/09553002.2018.1490037. Epub 2018 Aug 21.

PMID:
29912595
12.

Ionizing Radiation Induces Morphological Changes and Immunological Modulation of Jurkat Cells.

Voos P, Fuck S, Weipert F, Babel L, Tandl D, Meckel T, Hehlgans S, Fournier C, Moroni A, Rödel F, Thiel G.

Front Immunol. 2018 Apr 30;9:922. doi: 10.3389/fimmu.2018.00922. eCollection 2018.

13.

Anal squamous cell carcinoma - State of the art management and future perspectives.

Martin D, Balermpas P, Winkelmann R, Rödel F, Rödel C, Fokas E.

Cancer Treat Rev. 2018 Apr;65:11-21. doi: 10.1016/j.ctrv.2018.02.001. Epub 2018 Feb 22. Review.

PMID:
29494827
14.

Differential effects of α-catenin on the invasion and radiochemosensitivity of human colorectal cancer cells.

Förster S, Hehlgans S, Rödel F, Otto B, Cordes N.

Int J Oncol. 2018 Apr;52(4):1117-1128. doi: 10.3892/ijo.2018.4279. Epub 2018 Feb 21.

15.

Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Stangl S, Tontcheva N, Sievert W, Shevtsov M, Niu M, Schmid TE, Pigorsch S, Combs SE, Haller B, Balermpas P, Rödel F, Rödel C, Fokas E, Krause M, Linge A, Lohaus F, Baumann M, Tinhofer I, Budach V, Stuschke M, Grosu AL, Abdollahi A, Debus J, Belka C, Maihöfer C, Mönnich D, Zips D, Multhoff G.

Int J Cancer. 2018 May 1;142(9):1911-1925. doi: 10.1002/ijc.31213. Epub 2017 Dec 23.

16.

Prognostic impact of RITA expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy.

Rödel F, Steinhäuser K, Kreis NN, Friemel A, Martin D, Wieland U, Rave-Fränk M, Balermpas P, Fokas E, Louwen F, Rödel C, Yuan J.

Radiother Oncol. 2018 Feb;126(2):214-221. doi: 10.1016/j.radonc.2017.10.028. Epub 2017 Nov 6.

PMID:
29122359
17.

Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer.

Martin D, Rödel F, Winkelmann R, Balermpas P, Rödel C, Fokas E.

Front Immunol. 2017 Sep 29;8:1225. doi: 10.3389/fimmu.2017.01225. eCollection 2017.

18.

A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma.

Wagner J, Pfannenstiel V, Waldmann A, Bergs JWJ, Brill B, Huenecke S, Klingebiel T, Rödel F, Buchholz CJ, Wels WS, Bader P, Ullrich E.

Front Immunol. 2017 Jun 12;8:676. doi: 10.3389/fimmu.2017.00676. eCollection 2017.

19.

Measuring Leukocyte Adhesion to (Primary) Endothelial Cells after Photon and Charged Particle Exposure with a Dedicated Laminar Flow Chamber.

Erbeldinger N, Rapp F, Ktitareva S, Wendel P, Bothe AS, Dettmering T, Durante M, Friedrich T, Bertulat B, Meyer S, Cardoso MC, Hehlgans S, Rödel F, Fournier C.

Front Immunol. 2017 Jun 1;8:627. doi: 10.3389/fimmu.2017.00627. eCollection 2017.

20.

Erratum to: Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters.

Yildirim M, Müller von der Grün J, Winkelmann R, Fokas E, Rödel F, Ackermann H, Rödel C, Balermpas P.

Strahlenther Onkol. 2017 Aug;193(8):682. doi: 10.1007/s00066-017-1155-4. No abstract available.

PMID:
28540428

Supplemental Content

Loading ...
Support Center